A post hoc analysis of the DUAL V and DUAL VIII trials compared derived-TIR, calculated from self-monitored blood glucose, with IDegLira versus insulin glargine 100 units/mL (glargine U100) in people with T2D [19]. Here, INS is linked to type 2 diabetes mellitus.